Novo Tanks 25% on Surprise Demand Drop

Benzinga

Novo Nordisk just suffered its worst day in history, losing over $100 billion in market value after Wegovy sales plunged. With over 1 million Americans turning to off-brand knockoffs, profits are evaporating — and lawsuits are flying. Novo has slashed its 2025 forecast again, leaving investors to wonder: is this just a bump in the road, or is the entire weight loss drug industry about to unravel?

Transcript

00:00Novo Nordisk just lost $100 billion and the entire weight loss industry is shaking.

00:05The company behind the blockbuster obesity drug called WeGoV had its worst day in history

00:11down 25% in a single day, and now 65% from its peak.

00:16Why?

00:17Because their miracle drug isn't selling like it used to.

00:19Turns out over 1 million patients in the US are taking off-brand knockoffs of WeGoV,

00:24cutting into profits big time.

00:26Novo even sued telehealth firms like hims and hers for pushing these unregulated versions.

00:31And now they've slashed their 2025 forecast for sales and profits again.

00:37Is this the beginning of the end for the weight loss drug boom or just a blip in a multi-billion

00:42dollar trend?

Category

Transcript

Recommended